1776 Wealth LLC Vertex Pharmaceuticals Inc Transaction History

1776 Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $35,279 - $41,827	-138 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$225.48 - $295.8 $12,852 - $16,860	-57 Reduced 29.23%	138 $40,000
Q1 2020 Apr 23, 2020	BUY	$199.77 - $247.81 $8,190 - $10,160	41 Added 26.62%	195 $46,000
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $25,673 - $34,482	154 New	154 $33,000

1,725

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of 1776 Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on 1776 Wealth LLC with notifications on news.